Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1742694

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1742694

Dermatology Devices Market - Forecasts from 2025 to 2030

PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The Dermatology Devices Market is expected to grow from US$22.633 billion in 2025 to US$30.641 billion in 2030, at a CAGR of 6.25%.

The growing prevalence of skin problems like skin rash, acne, and mycosis along with the increasing awareness about aesthetic procedures are considered as the driving force for the growth of the market. Growing health care expenditure and increasing demand for non-invasive cosmetic correction procedures are also expected to fuel the growth of the dermatology devices market. However, a complication associated with dermatological treatments is considered as a restraining factor for the growth of the market.

Global Dermatology Devices Market Key Drivers:

  • Growing prevalence of skin diseases and problems.

Some of the most common types of skin conditions are acne, atopic dermatitis, hair loss, skin cancer, and other related conditions. According to the data given by the American Academy of Dermatology, acne has become the most common skin problem and condition in the United States, in the past few years. Around 50 million Americans are being affected by acne, per year. Moreover, the total treatment costs associated with the treatment amounted to more than US$1.2 billion in the United States. Major companies and organizations have been introducing novel and advanced solutions to treat this condition, for the past few years. Various studies have stated that laser and other light treatments are required to reduce acne. The United States Food and Drug Administration had already approved some types of visible light LED devices, such as red, blue, and blue+red devices, for home use. These trends are expected to have a positive impact on the market, in the coming years.

  • The rising rate of skin cancer.

The market is expected to surge in the coming years, due to the increasing prevalence rate of skin cancer, globally. According to the data given by the American Institute for Cancer Research and World Cancer Research Fund, skin cancer has become the 19th most common cancer, globally. Around 300,000 novel cases of melanoma skin cancer were found in the year 2018 and 2019. Non-melanoma skin cancer has also become a major concern in both men and women. Over one million diagnoses were reported in the year 2019. Major companies and organizations have been making significant developments in the market, in the past few years. The development of novel and advanced solutions is also expected to play a crucial role in the overall market growth. For instance, the DermaSensor had been created to help overcome the major challenges, that are associated with a conventional skin cancer diagnosis. The novel device has been a handled objective skin cancer that utilizes and uses both light and pulses and spectroscopy to identify and find information about a skin lesion. These trends are expected to have a positive impact on the market, in the coming years.

Global Dermatology Devices Market Geographical Analysis:

  • The United States is expected to have a major share.

The United States is expected to have a major share in the market, due to the increasing prevalence of skin diseases and conditions in the country. For instance, in the United States, around one in ten people usually develops atopic dermatitis, during their respective lifetime. Hair loss has also become one of the major concerns in the country. The most common cause of hair loss is baldness or hereditary thinning, which is also called androgenetic alopecia. According to the data given by the American Academy of Dermatology Association, hair loss conditions had affected an estimated number of 80 million Americans, with around 30 million women and 50 million men. Another skin condition such as Psoriasis has also become a major concern in the country. Around 7.5 million people have psoriasis in the United States. More than US$50 billion is spent in the treatment of psoriasis in the country, per year. These trends and numbers are expected to surge the adoption of novel and advanced dermatology devices in the country, during the forecast period.

Global Dermatology Devices Market Key Developments:

The market is expected to grow at a significant rate in the coming years, due to the rise in the number of innovative, advanced, and new solutions. Major companies, R&D institutions, and organizations have been making a considerable impact in the market.

  • In June 2021, Aesthetics Biomedical, a topical skincare product development, and aesthetic device company announced that it had been given FDA clearance for their Vivace radiofrequency micro-needling device for its use at both 1MHz and 2MHz frequency. The novel device had been designed to treat different signs of aging, which includes skin laxity and wrinkles.
  • In June 2021, Eclipse, a major medical and aesthetic manufacturer, announced that it had been given FDA clearance of its latest and novel grade micro-needling device, known as the MicroPen EVO. The device would be available in aesthetic and dermatology practices in the United States.

Global Dermatology Devices Market Segmentation:

By Type of Diagnostic Devices

  • Dermatoscopes
  • Microscopes
  • Imaging Devices
  • Others

By Type of Treatment Devices

  • Laser-based Devices
  • Light-Based Devices
  • Radiofrequency (RF) Devices
  • Cryotherapy Devices
  • Microdermabrasion Devices
  • Microneedling Devices
  • Phototherapy Devices
  • Electrosurgical Equipment
  • Others

By Application

  • Skin Cancer Diagnosis
  • Hair Removal
  • Acne & Psoriasis Treatment
  • Wrinkle & Scar Reduction
  • Skin Rejuvenation
  • Tattoo & Lesion Removal

By End-Users

  • Hospitals
  • Dermatology Clinics
  • Ambulatory Surgical Centers
  • Medical Spas
  • Homecare Settings

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others
Product Code: KSI061611732

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL DERMATOLOGY DEVICES MARKET BY TYPE OF DIAGNOSTIC DEVICES

  • 5.1. Introduction
  • 5.2. Dermatoscopes
  • 5.3. Microscopes
  • 5.4. Imaging Devices
  • 5.5. Others

6. GLOBAL DERMATOLOGY DEVICES MARKET BY TYPE OF TREATMENT DEVICES

  • 6.1. Introduction
  • 6.2. Laser-based Devices
  • 6.3. Light-Based Devices
  • 6.4. Radiofrequency (RF) Devices
  • 6.5. Cryotherapy Devices
  • 6.6. Microdermabrasion Devices
  • 6.7. Microneedling Devices
  • 6.8. Phototherapy Devices
  • 6.9. Electrosurgical Equipment
  • 6.10. Others

7. GLOBAL DERMATOLOGY DEVICES MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Skin Cancer Diagnosis
  • 7.3. Hair Removal
  • 7.4. Acne & Psoriasis Treatment
  • 7.5. Wrinkle & Scar Reduction
  • 7.6. Skin Rejuvenation
  • 7.7. Tattoo & Lesion Removal

8. GLOBAL DERMATOLOGY DEVICES MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Dermatology Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Medical Spas
  • 8.6. Homecare Settings

9. GLOBAL DERMATOLOGY DEVICES MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type of Diagnostic Devices
    • 9.2.2. By Type of Treatment Devices
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Type of Diagnostic Devices
    • 9.3.2. By Type of Treatment Devices
    • 9.3.3. By Application
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Type of Diagnostic Devices
    • 9.4.2. By Type of Treatment Devices
    • 9.4.3. By Application
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Type of Diagnostic Devices
    • 9.5.2. By Type of Treatment Devices
    • 9.5.3. By Application
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Type of Diagnostic Devices
    • 9.6.2. By Type of Treatment Devices
    • 9.6.3. By Application
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Candela Corporation
  • 11.2. Quanta Systems S.p.A.
  • 11.3. Cynosure LLC
  • 11.4. Alma Lasers Ltd.
  • 11.5. Lumenis Ltd.
  • 11.6. Cutera Inc.
  • 11.7. Genesis Biosystems Inc.
  • 11.8. 3Gen Inc.
  • 11.9. Aesthetics Biomedical Inc.
  • 11.10. Canfield Scientific Inc.
  • 11.11. Solta Medical Inc.
  • 11.12. Michelson Diagnostics Ltd.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!